Case Report: Management of multiple brown tumors after kidney transplantation.

IF 4.6 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Frontiers in Endocrinology Pub Date : 2025-09-16 eCollection Date: 2025-01-01 DOI:10.3389/fendo.2025.1645715
Qingyi Sun, Yafei Bai, Ruman Chen, Hong Li
{"title":"Case Report: Management of multiple brown tumors after kidney transplantation.","authors":"Qingyi Sun, Yafei Bai, Ruman Chen, Hong Li","doi":"10.3389/fendo.2025.1645715","DOIUrl":null,"url":null,"abstract":"<p><p>Brown tumor is usually caused by primary or secondary hyperparathyroidism but is exceptionally rare after kidney transplantation. Their rarity and atypical pathological features make diagnosis and treatment particularly challenging. We present a case of a 38-year-old woman with multiple brown tumors secondary to persistent hyperparathyroidism following kidney transplantation. The patient was initially admitted to the orthopedic department for left shoulder dislocation and lytic lesions in the left humerus and was diagnosed with a giant cell tumor of bone. Further investigations revealed elevated parathyroid hormone (PTH) levels and multiple lytic bone lesions throughout the skeleton. Based on these findings, the patient was ultimately diagnosed with multiple brown tumors. As a result, the patient underwent total parathyroidectomy and autotransplantation of parathyroid tissue. Follow-up evaluations showed decreased PTH levels and alkaline phosphatase levels, with improvement in skeletal changes. This case report shares the experience and lessons in managing hyperparathyroidism, both before and after kidney transplantation, emphasizing the importance of clinicians' awareness of the disease and multidisciplinary collaborative management.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"16 ","pages":"1645715"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479324/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fendo.2025.1645715","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Brown tumor is usually caused by primary or secondary hyperparathyroidism but is exceptionally rare after kidney transplantation. Their rarity and atypical pathological features make diagnosis and treatment particularly challenging. We present a case of a 38-year-old woman with multiple brown tumors secondary to persistent hyperparathyroidism following kidney transplantation. The patient was initially admitted to the orthopedic department for left shoulder dislocation and lytic lesions in the left humerus and was diagnosed with a giant cell tumor of bone. Further investigations revealed elevated parathyroid hormone (PTH) levels and multiple lytic bone lesions throughout the skeleton. Based on these findings, the patient was ultimately diagnosed with multiple brown tumors. As a result, the patient underwent total parathyroidectomy and autotransplantation of parathyroid tissue. Follow-up evaluations showed decreased PTH levels and alkaline phosphatase levels, with improvement in skeletal changes. This case report shares the experience and lessons in managing hyperparathyroidism, both before and after kidney transplantation, emphasizing the importance of clinicians' awareness of the disease and multidisciplinary collaborative management.

病例报告:肾移植术后多发棕色肿瘤的处理。
棕色肿瘤通常由原发性或继发性甲状旁腺功能亢进引起,但在肾移植后极为罕见。其罕见和非典型的病理特征使诊断和治疗特别具有挑战性。我们报告一位38岁的女性,肾脏移植后继发于持续性甲状旁腺功能亢进的多发棕色肿瘤。患者最初因左肩脱位和左肱骨溶解性病变入院骨科,诊断为骨巨细胞瘤。进一步的调查显示甲状旁腺激素(PTH)水平升高和整个骨骼的多发性溶解性骨病变。基于这些发现,患者最终被诊断为多发性棕色肿瘤。结果,患者接受了甲状旁腺全切除术和自体甲状旁腺组织移植。随访评估显示甲状旁腺激素水平和碱性磷酸酶水平下降,骨骼变化改善。本病例报告分享了在肾移植前后治疗甲状旁腺功能亢进的经验教训,强调临床医生对疾病的认识和多学科合作治疗的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Endocrinology
Frontiers in Endocrinology Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
5.70
自引率
9.60%
发文量
3023
审稿时长
14 weeks
期刊介绍: Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series. In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology. Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信